chr15-39589264-C-A
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_003246.4(THBS1):c.1836C>A(p.Asp612Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000958 in 1,461,850 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_003246.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
THBS1 | NM_003246.4 | c.1836C>A | p.Asp612Glu | missense_variant | 12/22 | ENST00000260356.6 | |
THBS1 | XM_047432980.1 | c.1836C>A | p.Asp612Glu | missense_variant | 12/22 | ||
THBS1 | XM_011521971.3 | c.1662C>A | p.Asp554Glu | missense_variant | 11/21 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
THBS1 | ENST00000260356.6 | c.1836C>A | p.Asp612Glu | missense_variant | 12/22 | 1 | NM_003246.4 | P1 | |
THBS1 | ENST00000490247.1 | n.302C>A | non_coding_transcript_exon_variant | 2/3 | 2 | ||||
FSIP1 | ENST00000642527.1 | c.*215-690G>T | intron_variant, NMD_transcript_variant |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD4 exome AF: 0.00000958 AC: 14AN: 1461850Hom.: 0 Cov.: 32 AF XY: 0.00000963 AC XY: 7AN XY: 727226
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 04, 2022 | The c.1836C>A (p.D612E) alteration is located in exon 12 (coding exon 11) of the THBS1 gene. This alteration results from a C to A substitution at nucleotide position 1836, causing the aspartic acid (D) at amino acid position 612 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
No publications associated with this variant yet.